Loading...
NASDAQ: SNDL
SNDL Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Market Cap
$360.29M
52w High
$2.89
52w Low
$1.15
P/E
-31.57
Volume
1.31M
Outstanding Shares
259.20M
Company profile
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada.
CEOZachary Ryan George
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,604
IPO dateAug 1, 2019
Valuation
Forward P/E—
EV/EBITDA10.40
Enterprise value$485.28M
Stock splits
Jul 26, 20221:10
Profitability & growth
Revenue growth-3.57%
Gross margin25.98%▼16.35%vs FY2024
Operating margin-0.85%▲95.78%vs FY2024
ROE-1.41%▲83.20%vs FY2024
Analyst consensus
RatingHold
Target price$3.95▲184.17%
1
Buy
5
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 13, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.01
-$0.04
Q3FY25
ActualEst.
-$0.04
-$0.00
Q4FY25
ActualEst.
$0.03
$0.01
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$179.66M
$242.98M
Q3FY25
ActualEst.
$175.1M
$257.97M
Q4FY25
ActualEst.
$183.87M
$189.68M
Q1FY26
Next Est.
—